Atom Investors LP Aclaris Therapeutics, Inc. Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $146,570 - $244,655
22,343 New
22,343 $153,000
Q4 2021

Feb 14, 2022
SELL
$12.27 - $18.49 $309,167 - $465,892
-25,197 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$13.38 - $18.8 $2.11 Million - $2.96 Million
-157,393 Reduced 86.2%
25,197 $454,000
Q2 2021

Aug 16, 2021
BUY
$17.08 - $29.6 $3.12 Million - $5.4 Million
182,590 New
182,590 $3.21 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email